All material subject to strictly enforced copyright laws. © 2022 Euromoney Institutional Investor PLC group
Syndicated Loans

GSK agrees $5.1bn price for cancer drug company

Glaxo 230x150 Brentford HQ

The UK’s GlaxoSmithKline has agreed to buy US oncology company Tesaro for $5.1bn, as 'long overdue' consolidation in the pharmaceutical sector continues apace.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Take a Free Trial or Login
We use cookies to provide a personalized site experience.
By continuing to use & browse the site you agree to our Privacy Policy.
I agree